|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of net revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Distribution | |||||
| Impairment loss of consolidated statements of operations | |||||
| Change in fair value of contingent consideration | |||||
| Impairment of goodwill and intangible assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Other non-operating (expense) income | |||||
| Other income (expense): | |||||
| Change in fair value of share based payment liability | |||||
| Interest expense | |||||
| Other non-operating expenses | |||||
| Other non-operating income (expenses) | |||||
| Total other income (expense), net | |||||
| Income tax benefit (provision) | |||||
| Net loss from continuing operations | |||||
| (Loss) from discontinued operations, net of tax | |||||
| Net loss | |||||
| Deemed dividend on modification of Series D preferred stock | |||||
| Net loss attributable to common stockholders | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
| Net loss from continuing per common share - basic | |||||
| Net loss per common share - basic | |||||
| Net loss per common share - diluted |
Loading...